Reduction of applicator displacement in MR/CT-guided cervical cancer HDR brachytherapy by the use of patient hover transport system

Megan Andrew, Yusung Kim, PhD, Timothy Ginader, MS, Brian J. Smith, PhD, Wenqing Sun, MD, PhD, and Dongxu Wang, PhD
J Contemp Brachytherapy. 2018 Feb; 10(1): 85–90.
Published online 2018 Feb 26. doi: 10.5114/jcb.2018.73755

Improving the efficiency of image-guided brachytherapy in cervical cancer

Sophie Otter, MBBChir, MRCP, FRCR, Adrian Franklin, MBBS, MRCP, FRCR, Mazhar Ajaz, PhD, MRCP, FRCR, and Alexandra Stewart, MD, FRCR, MRCP
J Contemp Brachytherapy. 2016 Dec; 8(6): 557–565.
Published online 2016 Dec 6. doi: 10.5114/jcb.2016.64452

Dosimetric impacts of applicator displacements and applicator reconstruction-uncertainties on 3D image-guided brachytherapy for cervical cancer

Joshua Schindel, BS, Winson Zhang, Sudershan K. Bhatia, MD, PhD, MPH, Wenqing Sun, MD, PhD, and Yusung Kim, PhD
J Contemp Brachytherapy. 2013 Dec; 5(4): 250–257.
Published online 2013 Dec 18. doi: 10.5114/jcb.2013.39453

MUSC - Medical University South Carolina Hollings Cancer Center
Tailor Made - Personalizing Internal Radiotherapy for Locally Advanced Gynecologic Cancer

“Combined use of computed tomography (CT) and magnetic resonance imaging (MRI) yields the best results, as CT is useful for visualizing tissues and organs but can overestimate the size of the tumor, whereas MRI is the superior imaging tool for visualizing the tumor itself. In addition, a specialized hover bed, the Zephyr patient transfer system, is used to “hover” the patient between the operating room table as well as the CT and MR without having to lift her. This decreases the risk of applicator displacement and ensures treatment accuracy.”